000 | 01968 a2200577 4500 | ||
---|---|---|---|
005 | 20250517154854.0 | ||
264 | 0 | _c20180619 | |
008 | 201806s 0 0 eng d | ||
022 | _a1938-0690 | ||
024 | 7 |
_a10.1016/j.cllc.2017.04.006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMartín Martorell, Paloma | |
245 | 0 | 0 |
_aCoexistence of EGFR, KRAS, BRAF, and PIK3CA Mutations and ALK Rearrangement in a Comprehensive Cohort of 326 Consecutive Spanish Nonsquamous NSCLC Patients. _h[electronic resource] |
260 |
_bClinical lung cancer _c11 2017 |
||
300 |
_ae395-e402 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aAnaplastic Lymphoma Kinase |
650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xgenetics |
650 | 0 | 4 |
_aClass I Phosphatidylinositol 3-Kinases _xgenetics |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 |
_aErbB Receptors _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Rearrangement |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung Neoplasms _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aProto-Oncogene Proteins B-raf _xgenetics |
650 | 0 | 4 |
_aProto-Oncogene Proteins p21(ras) _xgenetics |
650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xgenetics |
650 | 0 | 4 | _aSpain |
700 | 1 | _aHuerta, Marisol | |
700 | 1 | _aCompañ Quilis, Amparo | |
700 | 1 | _aAbellán, Rosario | |
700 | 1 | _aSeda, Enrique | |
700 | 1 | _aBlesa, Sebastián | |
700 | 1 | _aChaves, Felipe J | |
700 | 1 | _aDualde Beltrán, Diego | |
700 | 1 | _aRoselló Keränen, Susana | |
700 | 1 | _aFranco, José | |
700 | 1 | _aInsa, Amelia | |
773 | 0 |
_tClinical lung cancer _gvol. 18 _gno. 6 _gp. e395-e402 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cllc.2017.04.006 _zAvailable from publisher's website |
999 |
_c27216250 _d27216250 |